TGF-? receptor complex is a new addition to the family of human tumor suppressor genes and inactivation of these receptors is important in multiple human malignancies. Because human cancer cells frequently demonstrate resistance to the normal growth inhibitory effects of TGF-?, it has been proposed that the development of such TGF-? resistance represents a significant step during carcinogenesis. We have demonstrated a strong correlation between the resistance to TGF-? and gross structural abnormalities in the TGF-? type II receptor (RII) gene in human gastric cancers. In addition, we have reported that mutation and transcriptional repression of the TGF-? type II receptor correlated with the loss of responsiveness of tumor cell lines to TGF-?. Transcriptional repression of the TGF-? type II receptor (T?RII) gene is one of several mechanisms leading to TGF-? resistance. Our research has suggested that a pharmacologic augmentation of TGF-beta signaling pathways in human cancers such as gastric cancer may be a potential therapeutic strategy. Previously, we showed that MS-275, a synthetic inhibitor of histone deacetylase (HDAC), specifically induces the expression of the T?RII gene and restores the TGF-? signaling in human breast cancer cell lines. In our recent study, we demonstrated that treatment with the HDAC inhibitor induces T?RII promoter activity by the recruitment of PCAF protein to the NF-Y complex interacting with the inverted CCAAT box in the T?RII promoter. It has been shown that infection of cells with human T-cell lymphotropic virus-1 (HTLV-1), hepatitis B virus (HBV), and human papillomavirus (HPV) modulates TGF-? signaling. We, therefore, explored the molecular mechanisms of suppression of TGF-? signaling by viral oncoproteins, such as HBV-pX, HTLV-1-Tax, or HPV-E7. We discovered that the HBV encoded oncoprotein pX amplifies and augments TGF-? signaling through a direct interaction with its signaling intermediate, Smad4. This observation led to a mechanism of disease pathogenesis following HBV infection. The HTLV-I oncoprotein Tax is implicated in the various clinical manifestations associated with infection by HTLV-1 including an aggressive and fatal T-cell malignancy. A previous report demonstrated that HTLV-1-infected T-cell lines became resistant to TGF-? growth inhibitory activity. We found that Tax suppresses TGF-? signaling through direct interaction with Smad proteins, suggesting that the inhibition of TGF-? signaling by Tax may lead to the HTLV-1-associated leukemogenesis. The human papillomavirus (HPV) oncoprotein E7 is implicated in the etiology of cervical cancer associated with infection by HPV. HPV-positive cells develop resistance to TGF-? growth inhibitory activity through the inhibition of hypophosphorylation of pRb by papillomavirus type 16 E7 oncoprotein. We have demonstrated that E7, in addition to its well-known effects on pRb, significantly blocks both Smad transcriptional activity and the ability of TGF-? to inhibit DNA synthesis. E7 interacts constitutively with Smad2, Smad3, and Smad4, and blocks Smad3 binding to its target sequence on DNA. Our results suggest that suppression of Smad-mediated signaling by E7 may contribute to HPV-associated carcinogenesis.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005617-14
Application #
6761574
Study Section
(LCRC)
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Lee, H-J; Yun, C-H; Lim, S H et al. (2007) SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling. Oncogene 26:173-85
Lucas, Philip J; Kim, Seong-Jin; Mackall, Crystal L et al. (2006) Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice. Blood 108:2789-95
Kim, Byung-Gyu; Li, Cuiling; Qiao, Wenhui et al. (2006) Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441:1015-9
Choi, Kyung-Chul; Lee, Youn Sook; Lim, Seunghwan et al. (2006) Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol 7:1057-65
Zhang, Qiang; Yang, Ximing J; Kundu, Shilajit D et al. (2006) Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle. Mol Cancer Ther 5:1733-43
Zhang, Qiang; Jang, Thomas L; Yang, Ximing et al. (2006) Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells. Prostate 66:235-47
Zhang, Qiang; Rubenstein, Jonathan N; Jang, Thomas L et al. (2005) Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP). Mol Endocrinol 19:2390-9
Zhang, Qiang; Yang, Ximing; Pins, Michael et al. (2005) Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer. Cancer Res 65:1761-9
Ju, Eun Mi; Choi, Kyung-Chul; Hong, Seung-Hee et al. (2005) Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt. Biochem Biophys Res Commun 328:1170-81
Yoo, Byung-Moo; Oh, Tae-Young; Kim, Young-Bae et al. (2005) Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model. Pancreatology 5:165-76

Showing the most recent 10 out of 31 publications